Abstract:Background/Aims: Aberrant activation of the Wnt/β-catenin signaling pathway plays a key role in the pathogenesis of multiple tumors including digestive cancers. Recent studies have reported that Dickkopf-related protein 2 (DKK2) is epigenetically inactivated in numerous types of cancers and that its gene products exhibit tumor-suppressive properties. However, the biological functions and underlying molecular mechanisms of DKK2 in colon carcinoma remains obscure. Methods: We examined the expression of DKK2 in colon tumor cell lines by RT-PCR and its promoter methylation status in colon tumor cell lines and primary tumors by methylation-specific PCR (MSP). Ectopic expression of DKK2 was measured by RT-PCR prior to the other experiments. To investigate the function of DKK2, we assayed colony formation and cell proliferation, utilized flow cytometric analyses of the cell cycle and acridine orange/ethidium bromide (AO/EB) fluorescence staining for apoptosis, and examined wound healing, transwell migration and tumor growth in vivo. Western blots were used to explore the mechanisms of DKK2 in epithelial- mesenchymal transition and canonical Wnt/β-catenin signaling. Results: We show here that downregulation or silencing of DKK2 was closely associated with the hypermethylation status of its promoter and that DKK2 expression could be restored by demethylation treatment. Methylation of the DKK2 promoter was detected in nearly all tumors and tumor-adjacent tissues, but not in normal colon tissues. Ectopic expression of DKK2 in colon cell lines HCT116 and HT-29 inhibited colony formation and cell viability by inducing cell cycle G0/G1 arrest and apoptosis, and growth of stable DKK2-infected HCT116 cells in nude mice was decreased compared to controls. Furthermore, DKK2 restrained cell migration through partial reversal of epithelial-to- mesenchymal transition and also by downregulating several stem cell markers. Our data further showed that restoration of DKK2 expression resulted in downregulation of active β-catenin and its downstream target genes. Conclusion: DKK2 appears to be a functional tumor suppressor regulating tumorigenesis of colorectal cancer by antagonizing Wnt/β-catenin signaling.

The Suppressing Effects of Dkk3 Expression on Aggressiveness and Tumorigenesis of Colorectal Cancer

Role of REIC/Dkk-3 Protein in Tumorigenesis

M1617 PKCδ is a Negative Regulator of the Hedgehog Pathway by Inhibition of GLI Protein Transcriptional Activity

DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway

DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration

Epigenetic Silencing of the WNT Antagonist Dickkopf 3 Disrupts Normal Wnt/β-catenin Signalling and Apoptosis Regulation in Breast Cancer Cells.

Overexpression of Dickkopf-3 Induces Apoptosis Through Mitochondrial Pathway in Human Colon Cancer

FOXD3, Frequently Methylated in Colorectal Cancer, Acts As a Tumor Suppressor and Induces Tumor Cell Apoptosis under ER Stress Via P53.

Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling

Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.

Promoter methylation of the Wnt/β-catenin signaling antagonist<i>Dkk-3</i>is associated with poor survival in gastric cancer

Siprdx2-Elevated DNM3 Inhibits the Proliferation and Metastasis of Colon Cancer Cells Via AKT Signaling Pathway

Dkk-3, a Secreted Wnt Antagonist, Suppresses Tumorigenic Potential and Pulmonary Metastasis in Osteosarcoma.

Research progress of DDK-3 in tumor

Wnt Signaling Modulator DKK4 Inhibits Colorectal Cancer Metastasis Through an AKT/Wnt/β-catenin Negative Feedback Pathway.

Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma.

FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.

Dickkopf 1 Impairs the Tumor Response to PD-1 Blockade by Inactivating CD8+ T Cells in Deficient Mismatch Repair Colorectal Cancer

Dkk3 is A Potential Tumor Suppressor Gene in Papillary Thyroid Carcinoma

Dickkopf‐1 Expression is Down‐regulated During the Colorectal Adenoma–carcinoma Sequence and Correlates with Reduced Microvessel Density and VEGF Expression

The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma